Overview
Androgenic Profile Following Controlled Ovarian Stimulation
Status:
Unknown status
Unknown status
Trial end date:
2020-01-01
2020-01-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
In this study the investigators will try to discover whether there is a difference for any of the stimulation preparations - recombinant FSH + recombinant LH (pergoveris & luveris) vs. human menopausal gonadotropin (menopur) during GnRH-antagonist cycles in the meaning of androgenic hormones profile. The study question is whether using recombinant LH will result in different follicular hormonal milieu, serum endocrine profile or IVF outcomes than using highly purified urinary gonadotropins with hCG mimicking LH activity.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Sheba Medical CenterTreatments:
Menotropins
Criteria
Inclusion Criteria:- Infertile women between 20-40 years of age
- BMI 19-35
- undergoing their 1-4 IVF cycle
Exclusion Criteria:
- Suspected PCOS
- History of OHSS
- Patients who had a chronic illness or were receiving chronic medical treatment